ATLASSELLAS Life Sciences Group (SLS) earnings date: Nov 11, 2026
SELLAS Life Sciences Group (SLS) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 11, 2026 (confirmed), after the close. Analysts expect EPS of -$0.05. Free email alerts for this report are just below.
Source: company filings and exchange data · Updated Nov 3, 2026
ATLAS view on SLS
| Last price | $8.55 (-11.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.2% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the SELLAS Life Sciences Group stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Get an email before and after SELLAS Life Sciences Group reports, free with your ATLAS account
Earnings alerts are a free benefit of your ATLAS account. The company goes to your watchlist and we email you when it reports. Google signup is one click.
Create free accountSLS earnings at a glance
| Next report (confirmed) | Wed, Nov 11, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.05 |
| Last report | Aug 11, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | -1.0% |
| Average move around a report | ±7.1% (last 5) |
| Sector | Healthcare · Biotechnology |
SELLAS Life Sciences Group earnings history: last 5 reports
SELLAS Life Sciences Group last reported on Aug 11, 2026: EPS of -$0.05 against an estimate of -$0.04 (-25.0% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 11, 2026 | -$0.04 | -$0.05 | -25.0% | Miss | +6.6% |
| May 27, 2026 | $1.28 | $1.47 | +14.8% | Beat | +13.1% |
| Apr 28, 2026 | $4.82 | $4.97 | +3.1% | Beat | -4.3% |
| Apr 2, 2026 | -$0.62 | -$0.71 | -14.5% | Miss | +7.6% |
| Mar 19, 2026 | -$0.06 | -$0.05 | +16.7% | Beat | -3.8% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for SLS
See the fair value, the probability range and the earnings history of SELLAS Life Sciences Group on its ATLAS page.
SELLAS Life Sciences Group (SLS) stock analysisPlans from €3.99 a month.
SELLAS Life Sciences Group earnings: frequently asked questions
When does SELLAS Life Sciences Group (SLS) report earnings?
SELLAS Life Sciences Group is scheduled to report on Wednesday, November 11, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for SLS?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.05 per share (USD). Estimates can change before the report.
How often does SLS beat earnings estimates?
Of its last 5 reports with a recorded result, SELLAS Life Sciences Group beat the EPS estimate 3 times; the average surprise was -1.0%. Past results do not predict the next one.
How much does SLS move around earnings?
Over its last 5 reports the stock moved an average of 7.1% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did SELLAS Life Sciences Group beat earnings estimates last quarter?
SELLAS Life Sciences Group last reported on Aug 11, 2026: EPS of -$0.05 against an estimate of -$0.04 (-25.0% surprise), a miss.
How much does SLS usually move in a day?
On a normal trading day the ATLAS model puts SLS’s one-day range at about ±6.2%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 11, 2026
Educational information, not investment advice. Disclaimer